Lekoklar Xl

Clarithromycin, the active ingredient in Lekoklar Xl, is a macrolide antibiotic presented as an oral tablet for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, acute exacerbations of chronic bronchitis, skin and soft‑tissue infections, and is part of combination therapy for Helicobacter pylori eradication. GNH USA supplies Lekoklar Xl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is a macrolide antibiotic used to treat a range of bacterial infections. - Community‑acquired pneumonia: eliminates the causative bacteria and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute exacerbations of chronic bronchitis: controls bacterial overgrowth and eases breathing difficulties. - Skin and soft‑tissue infections: eradicates susceptible organisms and promotes wound healing. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance as part of a multi‑drug regimen.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort. - Altered taste: metallic or bitter sensation. - Headache: transient mild headache. - Vomiting: occasional emesis.

Serious or Rare Side Effects: - Hepatic dysfunction: elevated liver enzymes or jaundice. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - Clostridioides difficile colitis: severe diarrhea with pseudomembranous colitis. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: life‑threatening skin reactions. - Hepatotoxicity: rare cases of liver injury requiring monitoring.

Before initiating therapy, consider the following precautions. - Renal or hepatic impairment: assess function and adjust therapy as needed. - Pregnancy and lactation: use only when benefits outweigh potential risks. - Concomitant QT‑prolonging drugs: monitor cardiac rhythm closely. - Known macrolide allergy: contraindicated due to risk of severe hypersensitivity. - Drug interaction review: evaluate all concurrent medications for potential interactions. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Clarithromycin interacts with several medicines; careful management is required.

Major Interactions (Avoid): - Erythromycin, ketoconazole, cisapride: may cause serious cardiac arrhythmias. - Simvastatin, lovastatin: increased statin concentrations leading to myopathy. - Pimozide: heightened risk of QT prolongation and ventricular arrhythmias.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR and bleeding risk. - Theophylline: may raise plasma levels causing toxicity. - Carbamazepine: can reduce clarithromycin concentrations, decreasing efficacy.